Paula Chamocho Lloro , María Dolores Rodríguez Garnica , Beatriz Sánchez Jimenez , Sergio Rodriguez Lobalzo , Angel Calvo Tudela , Alejandro J. Rohde Calleja , Francisco Rivas Ruiz , José C. Maañón di Leo
{"title":"Correlación entre la carga tumoral total de los ganglios linfáticos analizada mediante One Step Nucleic Acid Amplification (OSNA) y la decisión de realizar una linfadenectomía axilar en el cáncer de mama temprano","authors":"Paula Chamocho Lloro , María Dolores Rodríguez Garnica , Beatriz Sánchez Jimenez , Sergio Rodriguez Lobalzo , Angel Calvo Tudela , Alejandro J. Rohde Calleja , Francisco Rivas Ruiz , José C. Maañón di Leo","doi":"10.1016/j.senol.2025.100667","DOIUrl":"10.1016/j.senol.2025.100667","url":null,"abstract":"<div><h3>Introduction</h3><div>The aim of this study was to determine the correlation between total lymph load (TLL) analyzed by one step nucleic acid amplification (OSNA) and the results obtained in our clinical practice, and whether TTL is a useful tool for selecting patients who should undergo axillary lymph node dissection.</div></div><div><h3>Material and methods</h3><div>The study has a retrospective cohort design, conducted at the Hospital Costa de Sol on 92 patients with (GC<!--> <!-->+) analyzed by OSNA, between 2012 and 2017.</div></div><div><h3>Results</h3><div>Disease-free survival was analyzed classifying patients into micro-metastatic, macro-metastatic with less than 25,000 copies of mRNA-CK19/ul, and macro-metastatic with more than 25,000 copies of mRNA-CK19/ul, with no statistical significance found between groups (log-rank test 0.266266).</div></div><div><h3>Discussion</h3><div>The recommendation of axillary lymph node dissection (ALND) in conservatively operated patients with clinically (or radiologically) negative axilla and high tumor load as determined by OSNA is not related to local disease control.</div></div>","PeriodicalId":38058,"journal":{"name":"Revista de Senologia y Patologia Mamaria","volume":"38 2","pages":"Article 100667"},"PeriodicalIF":0.3,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143341654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Del Ars Magna a la inteligencia artificial generativa","authors":"Rafael Berlanga Llavori","doi":"10.1016/j.senol.2024.100663","DOIUrl":"10.1016/j.senol.2024.100663","url":null,"abstract":"<div><div>This article aims to present the key elements in the evolution of Artificial Intelligence (AI) in recent years, especially Generative Artificial Intelligence. Predictive or discriminative AI has had a notable impact on medicine in the last two decades, especially in the diagnosis of pathologies based on clinical data. Now, generative AI leads us to new challenges and opportunities in numerous fields such as personalised treatment, prevention, pro-action, new therapeutic techniques and, in general, the broadening of the horizons of clinical and biomedical research. For this work, we have carried out a bibliographic study and organised it into the main ideas for the application of generative AI to medicine. The main result of this study is a set of potential applications of generative AI that are being initiated in several areas of medicine and that may lead to a revolution in medicine in the short to mid-term. However, there are major hurdles to overcome, mainly those concerning the quality and accuracy of these systems, as well as the privacy and ethical barriers that must be respected by the new automated healthcare systems.</div></div>","PeriodicalId":38058,"journal":{"name":"Revista de Senologia y Patologia Mamaria","volume":"38 3","pages":"Article 100663"},"PeriodicalIF":0.3,"publicationDate":"2025-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143132587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Miriam Alcaide Lucena , Carlos José Rodríguez González , Rafael Nieto Serrano , Jesús García Rubio , Benito Mirón Pozo
{"title":"¿Es posible realizar la biopsia selectiva de ganglio centinela (BSGC) en una paciente con mastectomía preservadora de piel y pezón? Descripción de un caso","authors":"Miriam Alcaide Lucena , Carlos José Rodríguez González , Rafael Nieto Serrano , Jesús García Rubio , Benito Mirón Pozo","doi":"10.1016/j.senol.2025.100665","DOIUrl":"10.1016/j.senol.2025.100665","url":null,"abstract":"<div><div>BRCA mutation carriers have an increased risk of breast cancer. Among the risk-reducing measures is prophylactic bilateral mastectomy. In less than 1% of BRCA patients undergoing this surgery, previously undetected breast cancer is found. Routine sentinel lymph node biopsy has not shown benefit because few patients have occult cancer, and it is a technique that also involves morbidity. If a carcinoma is found in the specimen, axillary staging should be done in a second procedure, which has traditionally been performed with lymphadenectomy due to the absence of breast tissue and the belief that sentinel lymph node biopsy (SLNB) is not feasible. We present the case of a patient diagnosed with an infiltrating tumor in the left mastectomy specimen, and successful SLNB performed in a second procedure. Four nodes were sent for intraoperative analysis with negative results. Axillary lymphadenectomy was avoided, achieving proper axillary staging. It is technically feasible to perform SLNB after a skin- and nipple-sparing mastectomy, avoiding systematic axillary lymphadenectomy for staging in these patients, thus avoiding the morbidity associated with this technique.</div></div>","PeriodicalId":38058,"journal":{"name":"Revista de Senologia y Patologia Mamaria","volume":"38 2","pages":"Article 100665"},"PeriodicalIF":0.3,"publicationDate":"2025-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143141960","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Noelia Lete Aguirre, Jorge Martínez Medel, Antonio Tomás Güemes Sánchez
{"title":"Cáncer de mama bilateral sincrónico en el varón. Descripción de un caso y revisión de la bibliografía","authors":"Noelia Lete Aguirre, Jorge Martínez Medel, Antonio Tomás Güemes Sánchez","doi":"10.1016/j.senol.2024.100664","DOIUrl":"10.1016/j.senol.2024.100664","url":null,"abstract":"<div><div>Male breast cancer is a rare entity, accounting for less than 1% of all diagnosed breast cancers. Risk factors include advanced age, obesity, testicular and liver diseases, and the presence of germline BRCA2 mutations. Even rarer is the occurrence of synchronous bilateral breast tumors, defined as tumors diagnosed within 12 months of the initial breast cancer. Due to its extreme rarity, few cases have been published in recent years, with most not referencing mutation studies. Greater awareness of the disease would prevent delays in both diagnosis and treatment.</div></div>","PeriodicalId":38058,"journal":{"name":"Revista de Senologia y Patologia Mamaria","volume":"38 2","pages":"Article 100664"},"PeriodicalIF":0.3,"publicationDate":"2025-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143141963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Beatriz Alonso De Castro , Cristina Reboredo Rendo , Fernanda Mosele , Eva Pérez López , Lourdes Calvo Martínez , Silvia Antolín Novoa
{"title":"Can we use HER2DX to modulate treatment intensity in HER2 positive early breast cancer?","authors":"Beatriz Alonso De Castro , Cristina Reboredo Rendo , Fernanda Mosele , Eva Pérez López , Lourdes Calvo Martínez , Silvia Antolín Novoa","doi":"10.1016/j.senol.2024.100659","DOIUrl":"10.1016/j.senol.2024.100659","url":null,"abstract":"<div><div>Clinical HER2 positive (cHER2<!--> <!-->+) breast cancer (BC) is an heterogenous disease, which represents a major challenge in the design of personalized therapeutic strategies. In recent years, a great development against HER2 targeted therapies took place, but not all patients benefit from the same regimens. In this context, it is essential to develop genomic analysis, with clinicopathological and molecular biomarkers, as HER2DX, in order to improve response, safety, and patient's quality of life. This review aims to comprehensively summarize the current evidence regarding the development, validation, and application of HER2DX score in clinical practice. Genomic development and clinical application in the identification of different cHER2<!--> <!-->+ BC populations are discussed, along as future changing strategies for escalation and de-escalation treatments.</div></div>","PeriodicalId":38058,"journal":{"name":"Revista de Senologia y Patologia Mamaria","volume":"38 3","pages":"Article 100659"},"PeriodicalIF":0.3,"publicationDate":"2025-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143132585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
David Anglada-Rotger , Sonia Rabanaque-Rodríguez , Laura Sáez-Parés , Jordi Temprana-Salvador
{"title":"Accelerating cancer diagnostics: A novel AI pipeline for efficient histopathological image analysis","authors":"David Anglada-Rotger , Sonia Rabanaque-Rodríguez , Laura Sáez-Parés , Jordi Temprana-Salvador","doi":"10.1016/j.senol.2024.100662","DOIUrl":"10.1016/j.senol.2024.100662","url":null,"abstract":"<div><div>The surge in digital pathology and the vast amount of data from whole slide images (WSIs) have made it essential to develop tools that can efficiently analyze and support cancer diagnosis. An innovative artificial intelligence-based pipeline has been developed to tackle this challenge, significantly speeding up and enhancing the accuracy of breast cancer diagnosis. Created within the DigiPatICS project, in partnership with 8 hospitals across Catalonia, Spain, this pipeline begins by identifying tissue areas in WSIs and breaking them down into smaller, manageable tiles. Using smart image processing techniques, it filters out tiles that do not contain relevant information and focuses on the essential ones. Advanced deep learning algorithms then work to identify and classify different types of cells within the tissue. Proven effective on key breast cancer markers like HER2, Ki67, ER, and PR, the system precomputes the results overnight, allowing pathologists to simply load the pre-analyzed data for the areas of interest of the WSI that they select during their workday. Each WSI is analyzed in more or less 1110 s, providing reliable results that are ready when needed. Now, an integral part of routine workflows, this approach is revolutionizing how breast cancer slides are processed, enhancing diagnostic capabilities, and reshaping digital pathology.</div></div>","PeriodicalId":38058,"journal":{"name":"Revista de Senologia y Patologia Mamaria","volume":"38 3","pages":"Article 100662"},"PeriodicalIF":0.3,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143132586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
José Richard Tenazoa-Villalobos , Edgar Fermín Yan-Quiroz , Gladys Llerena-Cobián
{"title":"Descripcion de un caso de carcinoma papilar encapsulado apocrino de mama: un dilema diagnóstico","authors":"José Richard Tenazoa-Villalobos , Edgar Fermín Yan-Quiroz , Gladys Llerena-Cobián","doi":"10.1016/j.senol.2024.100653","DOIUrl":"10.1016/j.senol.2024.100653","url":null,"abstract":"<div><div>Encapsulated papillary carcinoma of the breast with apocrine differentiation is an extremely rare neoplasm that possesses both an encapsulated papillary configuration as well as epithelial cells that differentiated apocrine. It is not included as such in the fifth edition of the World Health Organization (WHO) classification of tumors because there are no research studies on the subject. These neoplasms have cells that are distinguished by having granular cytoplasm, large nuclei with prominent nucleoli, through immunohistochemistry these tumors are negative for estrogen, progesterone and HER2 receptors, but despite the absence of these markers and the nuclear atypia described, they have an overall survival that exceeds 5 years compared even to the other types of triple-negative breast neoplasm. We present the case of an 85-year-old woman who presented a right breast tumor that was classified as apocrine encapsulated papillary carcinoma, underwent right total mastectomy surgery and allowed the control of the disease, thus achieving a favorable outcome.</div></div>","PeriodicalId":38058,"journal":{"name":"Revista de Senologia y Patologia Mamaria","volume":"38 2","pages":"Article 100653"},"PeriodicalIF":0.3,"publicationDate":"2025-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143141961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Los colgajos de perforantes en la cirugía del cáncer de mama","authors":"Ricardo Pardo Garcia","doi":"10.1016/j.senol.2024.100660","DOIUrl":"10.1016/j.senol.2024.100660","url":null,"abstract":"","PeriodicalId":38058,"journal":{"name":"Revista de Senologia y Patologia Mamaria","volume":"38 1","pages":"Article 100660"},"PeriodicalIF":0.3,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143161086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Ética y filosofía de la inteligencia artificial aplicada a la enfermedad mamaria","authors":"David Casacuberta","doi":"10.1016/j.senol.2024.100656","DOIUrl":"10.1016/j.senol.2024.100656","url":null,"abstract":"<div><div>This article addresses the ethical challenges of using AI in breast pathology detection, highlighting that algorithmic reliability is not sufficient without fairness. Based on Rawls' ideas of fairness, it discusses biases in data and algorithms that may affect accuracy in different populations. Furthermore, it criticizes dataism and proposes an approach that integrates ethical considerations into the development of medical AI applications from the outset.</div></div>","PeriodicalId":38058,"journal":{"name":"Revista de Senologia y Patologia Mamaria","volume":"38 2","pages":"Article 100656"},"PeriodicalIF":0.3,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143141959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Adenomioepitelioma de la mama","authors":"Xavier Bargalló , Lledó Cabedo , Esther Sanfeliu , Sergi Ganau , Belén Úbeda , Carla Sitges , Dominika Gasior , Isaac Cebrecos , Eduard Mensión","doi":"10.1016/j.senol.2024.100655","DOIUrl":"10.1016/j.senol.2024.100655","url":null,"abstract":"<div><h3>Objectives</h3><div>To perform a descriptive analysis of the clinical information and radiological findings, emphasizing those provided by magnetic resonance imaging of a single-center series of cases of adenomyoepithelioma of the breast.</div></div><div><h3>Material and methods</h3><div>Our series consists of 11 patients, most of them were diagnosed by ultrasound-guided core needle biopsy. In three cases, the initial diagnosis was papilloma, and adenomyoepithelioma was diagnosed by surgical excision or vacuum aspiration biopsy. In five cases, breast magnetic resonance was performed.</div></div><div><h3>Results</h3><div>Most of our cases were diagnosed by mammography from the population-based breast cancer screening program, with a mass or focal asymmetry being the most frequent presentations. Ultrasound show oval and well-defined mass with a tendency to form angles. The two malignant cases showed prominent vessels in the Doppler study. On magnetic resonance imaging, they are predominantly hyperintense on T2 without restriction in diffusion and with intense gadolinium uptake. Three cases (two malignant and one atypical) relapsed.</div></div><div><h3>Conclusion</h3><div>Small adenomyoepitheliomas may mimic fibroadenomas, although they show a certain tendency to show angled edges. Core needle biopsy is usually diagnostic, although it is sometimes difficult to differentiate adenomyoepithelioma from papilloma.</div><div>Magnetic resonance imaging does not help to suspect malignancy since most cases do not show restriction in diffusion. In our series, the presence of vessels in the Doppler study has shown some relation to atypical or malignant adenomyoepithelioma. Wide surgical removal is warranted in atypical or malignant cases.</div></div>","PeriodicalId":38058,"journal":{"name":"Revista de Senologia y Patologia Mamaria","volume":"38 2","pages":"Article 100655"},"PeriodicalIF":0.3,"publicationDate":"2024-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143141957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}